Thrombectomy using the EmboTrap device: core laboratory-assessed results in 201 consecutive patients in a real-world setting.

Patrick A BrouwerLeonard L L YeoAke HolmbergTommy AnderssonJens KollochÅsa KuntzeSöderqvistMarcus OhlssonStaffan HolminAnastasios Mpotsaris Vamsi Krishna Gontu Pervinder BhogalMichael Söderman

Published in: Journal of neurointerventional surgery (2018)

The Embotrap device has a high rate of successful reperfusion. Our core laboratory-audited single-center experience suggests the technical feasibility and safety of the Embotrap for first-line use in a real-world setting.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
acute ischemic stroke
chronic kidney disease
prognostic factors
heart failure
coronary artery disease
acute coronary syndrome
brain injury
atrial fibrillation
percutaneous coronary intervention